(European Society of Cardiology) Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with atrial fibrillation scheduled for elective cardioversion, according to late-breaking results from the EMANATE trial presented today in a Hot Line LBCT Session at ESC Congress. Rates of bleeding were similar between the two groups.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2vCXQKs
No comments:
Post a Comment